I-Flow Corporation Wins Patent Infringement Lawsuit Against Novacon Corporation
<<<LAKE FOREST, Calif.--(BUSINESS WIRE)--June 5, 2000--I-Flow Corporation (Nasdaq: IFLO) announced today that the United States District Court for the Central District of California has ordered Novacon Corporation to immediately stop importing, manufacturing, selling and distributing the DIB elastomeric pump from Japan which infringes the patent for I-Flow's Homepump Eclipse(R) in the United States.
"We are extremely pleased with this decision. I-Flow has invested substantial sums of money in developing the Homepump Eclipse and other cost-effective products for the pain management and infusion needs of patients," said Donald M. Earhart, I-Flow's chairman, president and chief executive officer.
"We invested the resources necessary to develop the technology incorporated in these products and to patent the technology. We believe the ability to develop innovative technology is one of I-Flow's primary competitive advantages and we always will vigorously defend our proprietary technology from infringement."
About I-Flow
I-Flow Corporation (www.i-flowcorp.com) designs, develops and markets technically advanced, low cost ambulatory infusion systems that are redefining the standard of care by providing life enhancing, cost effective solutions for pain management and infusion therapy.
The statements contained in this release which are not historical facts may be deemed to contain forward-looking statements with respect to events, the occurrence of which involve significant risks and uncertainties, including, without limitation, future demand for the Company's services, competition within the industry, and other risks or uncertainties detailed in the Company's Securities and Exchange Commission filings.
------------------------------------------------------------------------
Contact:
I-Flow Corporation
Gayle L. Arnold, 949/206-2700
www.i-flowcorp.com
or
Neil Berkman Associates
John Hicks, 310/277-5162
info@BerkmanAssociates.com>>> |
